March 2016

New Product - Eltroxin

Eltroxin (thyroxine sodium) is used as thyroid replacement therapy and is indicated for the management of demonstrated thyroid hormone deficiency. Eltroxin is also used to suppress thyrotropin (TSH) for the management of TSH responsive tumours of the thyroid. Eltroxin is contraindicated in untreated hyperthyroidism; uncorrected primary or secondary adrenal insufficiency; thyrotoxicosis; and acute MI uncomplicated by hypothyroidism. Eltroxin is not bioequivalent on a same dose basis with Eutroxsig/ Oroxine. Eltroxin is available as 25 mcg, 50 mcg, 75 mcg, 100 mcg, 125 mcg and 200 mcg tablets in packs of 200’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au